Leadership Overview
Columbia Care has 10 executives leading key functions including strategy, finance, marketing, information technology, legal, and operations.
Driven by a commitment to innovation, Columbia Care cultivates, manufactures, and provides cannabis products and related services, impacting the medical cannabis landscape through its multi-state operations.
Driven by a commitment to innovation, Columbia Care cultivates, manufactures, and provides cannabis products and related services, impacting the medical cannabis landscape through its multi-state operations.
Leadership Roles at Columbia Care
Richard Gehringer - Chief Executive Officer
Richard Gehringer, the Chief Executive Officer at Columbia Care, directs the overarching strategy and operational execution for the multi-state medical cannabis cultivator, manufacturer, and provider. Gehringer's leadership ensures alignment across all business units, driving growth and market penetration in the pharmaceutical and cannabis sectors. Overseeing the company's expansion initiatives, Richard Gehringer focuses on optimizing cultivation, manufacturing processes, and product distribution to meet evolving patient needs and regulatory requirements. This executive role involves fostering key stakeholder relationships and guiding the organization toward sustained profitability and industry leadership. The Chief Executive Officer's purview encompasses all aspects of Columbia Care's business, from product development to market access, ensuring a cohesive and forward-thinking approach to the complex cannabis industry.
Brendan Mallee - Chief Financial Officer
Brendan Mallee, the Chief Financial Officer at Columbia Care, manages all financial operations, including accounting, financial planning, and capital allocation. Mallee's responsibilities extend to ensuring fiscal integrity and driving financial strategies that support the company's growth objectives in the pharmaceutical and cannabis manufacturing sectors. Overseeing treasury functions and investor relations, Brendan Mallee provides critical financial insights to guide strategic decision-making. This role involves rigorous budget management, risk assessment, and the development of financial models to forecast performance and identify opportunities for efficiency. The Chief Financial Officer ensures Columbia Care maintains a strong financial foundation, enabling continued investment in cultivation, manufacturing, and service expansion across its multi-state operations.
Joe Cenzo - President & Owner
Joe Cenzo, the President & Owner at Columbia Care, provides foundational leadership and strategic direction for the company's operations in the medical cannabis sector. Cenzo's role involves guiding the overall vision and ensuring the successful execution of business objectives related to cultivation, manufacturing, and product provision. This executive position requires a deep understanding of the industry's regulatory environment and market dynamics. Joe Cenzo focuses on fostering a culture of excellence and innovation, driving the company's expansion and commitment to quality. The President & Owner's influence is critical in shaping Columbia Care's strategic path and maintaining its position as a leading provider of cannabis products and services.
Nicholas Bulthuis - President
Nicholas Bulthuis, the President at Columbia Care, directs significant operational segments and strategic initiatives within the company's multi-state framework. Bulthuis's leadership focuses on optimizing the cultivation and manufacturing processes, ensuring high-quality cannabis products and efficient service delivery. This role involves overseeing regional operations and driving performance improvements across various business units. Nicholas Bulthuis collaborates with executive leadership to identify growth opportunities and enhance market presence in the pharmaceutical and cannabis industries. The President's responsibilities are key to maintaining operational excellence and advancing Columbia Care's mission to provide comprehensive cannabis solutions.
Edward Tillinghast - President, The Aerospace & Defense Technology Club
Edward Tillinghast, the President, The Aerospace & Defense Technology Club at Columbia Care, leads initiatives focused on technological advancement and strategic partnerships within specialized industry sectors. Tillinghast's role involves fostering innovation and exploring new applications for technology, potentially impacting operational efficiencies or product development. This position requires a forward-thinking approach to identifying emerging trends and opportunities. Edward Tillinghast contributes to strategic discussions regarding technological integration and market positioning. The President, The Aerospace & Defense Technology Club's focus is on driving progress and exploring cutting-edge solutions relevant to the company's operational and developmental goals.
Jesse Channon - President
Jesse Channon, the President at Columbia Care, drives key strategic initiatives and operational oversight for significant business segments. Channon's leadership focuses on enhancing the company's market position through effective management of cultivation, manufacturing, and distribution channels for cannabis products. This role involves collaborating with executive teams to refine business strategies and ensure seamless execution across all operational areas. Jesse Channon is instrumental in fostering operational excellence and promoting innovation within the pharmaceutical and cannabis sectors. The President's contributions are vital to Columbia Care's ongoing success and expansion, ensuring alignment with the company's core mission and values.
Michael Johnson - MBA Candidate - Chief Marketing Officer Program
Michael Johnson, the MBA Candidate - Chief Marketing Officer Program at Columbia Care, spearheads initiatives within the marketing function, focusing on brand development and market penetration strategies for cannabis products and services. Johnson's current focus involves applying advanced marketing principles to enhance customer engagement and expand market reach within the pharmaceutical and cultivation sectors. This role entails analyzing market trends, identifying target demographics, and developing innovative campaigns to communicate the value of Columbia Care's offerings. The MBA Candidate - Chief Marketing Officer Program role supports the broader marketing leadership in executing strategies that drive revenue and build brand loyalty across the company's multi-state operations. Michael Johnson contributes to shaping the company's market presence and competitive positioning.
Bob Boer - Deputy Chief Information Officer
Bob Boer, the Deputy Chief Information Officer at Columbia Care, supports the strategic direction and operational management of the company's information technology infrastructure. Boer's focus involves enhancing technological capabilities to streamline operations in cultivation, manufacturing, and service delivery within the pharmaceutical and cannabis industries. This role contributes to the implementation of robust IT systems that ensure data security, operational efficiency, and scalability across all business functions. Overseeing key technology projects, Bob Boer works to integrate innovative solutions that support Columbia Care's multi-state expansion and regulatory compliance efforts. The Deputy Chief Information Officer plays a vital part in maintaining a secure and efficient technological backbone for the organization.
Robert De Boer - Deputy Chief Information Officer
Robert De Boer, the Deputy Chief Information Officer at Columbia Care, collaborates on the oversight of the company's technology landscape, ensuring systems support the intricate demands of cannabis cultivation, manufacturing, and distribution. De Boer's responsibilities include contributing to the development and execution of IT strategies that enhance operational efficiency and data integrity across the organization. This position involves supporting the implementation of advanced technological solutions to manage complex supply chains and regulatory reporting requirements within the pharmaceutical sector. Robert De Boer assists in maintaining a secure and reliable IT environment, crucial for Columbia Care's multi-state operations and commitment to product quality. The Deputy Chief Information Officer's efforts are integral to the company's technological advancement.
David Sirolly - Chief Legal Officer & General Counsel
David Sirolly, the Chief Legal Officer & General Counsel at Columbia Care, oversees all legal affairs and ensures compliance with the complex regulatory landscape governing the cannabis industry. Sirolly's expertise is critical in navigating legal challenges, managing corporate governance, and mitigating risk across the company's multi-state operations. This executive role involves advising on contracts, intellectual property, and litigation matters, safeguarding the company's interests. David Sirolly plays a pivotal part in shaping legal strategies that support Columbia Care's business objectives and maintain its reputation for integrity. The Chief Legal Officer & General Counsel ensures adherence to all applicable laws and regulations, facilitating responsible growth.
Explore Leadership Teams in Manufacturing
Founded in 1945, Pisa Pharmaceutical is a pharmaceutical development and distribution company. Pisa offers laboratory hosting, production, and development services. Pisa Pharmaceutical is headquartered out of Guadalajara, Mexico.
Company Leadership AJ
YP
PA
LM
Founded in 1945 and headquartered in Mandaluyong, Philippines Unilab is a manufacturer of pharmaceuticals and other similar products.
Company Leadership RG
SB
LV
JC
Founded in 1973 and headquartered in Bangalore, India, Micro Lab is a pharmaceutical manufacturer, wholesaler, and R&D company.
Company Leadership MH
RK
RB
PM
ImmunityBio is a vertically-integrated biotechnology company developing next-generation therapies and vaccines that bolster the natural immune system to defeat cancers and infectious diseases. The Companys range of immunotherapy and cell therapy platforms, alone and together, act to drive and sustain an immune response with the goal of creating durable and safe protection against disease. Designated an FDA Breakthrough Therapy, ANKTIVA is the first FDA-approved immunotherapy for non-muscle invasive bladder cancer CIS that activates natural killer cells, T cells, and memory T cells for a long-duration response. The Company is applying its science and platforms to treating cancers, including the development of potential cancer vaccines, as well as developing immunotherapies and cell therapies that we believe sharply reduce or eliminate the need for standard high-dose chemotherapy. These platforms and their associated product candidates are designed to be more effective, accessible, and easily administered than current standards of care in oncology and infectious diseases.
Company Leadership FJ
Frequently Asked Questions Regarding Columbia Care Top Executives and Leadership Team
